business π Zydus stock jumps after Q1 results; India business shines
Zydus Lifesciences shares saw a significant jump after announcing its first-quarter earnings report. The company, based in India, reported strong performance driven primarily by its Indian branded formulations business. For the June quarter, the company posted a revenue of βΉ8,017 crore, marking a 22% increase from the previous fiscal year. Despite this, the profit dropped by 35.9% to βΉ939.8 crore compared to last year's figure. Looking ahead, the company remains focused on sustaining growth across its international and MedTech sectors. π